Clinical Study of Apatinib as the Second-line Therapy in Malignant Melanoma
Clinical trial NCT03383237 · UNKNOWN
Trial details
- NCT number
- NCT03383237
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-29
- Primary completion
- 2018-11-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.